The only FDA approved technology for extracorporeal perfusion and preservation of donor hearts in the U.S.
The OCS Heart is a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state. By monitoring key parameters of the functioning heart, physicians may use their medical judgement to assess a potentially suitable heart’s condition and viability.
OCS Heart EXPAND Clinical Trial Results
U.S. pivotal trial to evaluate the Organ Care System for use with unutilized donor hearts that may not meet current standard acceptance criteria for transplantation.
270+ DCD Heart Transplants
OCS™ Heart is the only system used in DCD heart transplantation worldwide
With 75 patients enrolled, the following types of expanded criteria donor hearts were used:
37% – Expected ischemic time >4 hours
31% – 20 or more mins of down time
28% – LVEF of 40-50%
13% – Older donors >55 years
8% – Coronary artery disease
(31 Patients had 2 or more indications)